Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin in Hepatitis E-Induced Acute on Chronic Liver Failure
NCT01698723Phase 2Unknown
- Sponsor
- AIIMS New Delhi
- Start
- Sep 2012
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of ribavirin in acute-on-chronic liver failure (ACLF), hepatitis E (HEV), sponsored by AIIMS New Delhi. Status: unknown.
02
Drugs
ribavirin
03
Conditions
acute-on-chronic liver failure (ACLF)hepatitis E (HEV)
Beyond the preview
Go deeper on NCT01698723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01698723.